🇺🇸 FDA
Patent

US 11072636

Peptide for inhibiting angiogenesis and use thereof

granted A61KA61K38/00A61P

Quick answer

US patent 11072636 (Peptide for inhibiting angiogenesis and use thereof) held by CAREGEN CO., LTD. expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P35/00